ADAM17 and breast carcinoma: Third, cancer cells may also produce factors that affect TNF-α and IFN-γ stability as a mechanism of resistance, such as the metalloproteinase ADAM17, which degrades IFN-γ in MCF-7 and MDA-MB-453 breast cancer cell lines [35].